Home / Inspections / 1065389

FDA Inspection 1065389 — Padagis Israel Pharmaceuticals Ltd.

Padagis Israel Pharmaceuticals Ltd. — FEI 3001904238

The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on July 19, 2018 in Yerucham. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yerucham (Israel)

Facility

Other inspections at this facility

  • 1220679 (NAI Wed Sep 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1191880 (NAI Thu Oct 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099381 (NAI Thu Jun 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910286 (VAI Thu Jan 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 837639 (VAI Mon Aug 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources